Dong X - Search Results

1

Benchmark Study Based on 2P2I_DB to Gain Insights into the Discovery of Small-Molecule PPI Inhibitors.

Wang Z, Kang Y, Li D, Sun H, Dong X, Yao X, Xu L, Chang S, Li Y, Hou T. Wang Z, et al. Among authors: dong x. J Phys Chem B. 2018 Mar 8;122(9):2544-2555. doi: 10.1021/acs.jpcb.7b12658. Epub 2018 Feb 22. J Phys Chem B. 2018. PMID: 29420886

2

QSAR study of Akt/protein kinase B (PKB) inhibitors using support vector machine.

Dong X, Jiang C, Hu H, Yan J, Chen J, Hu Y. Dong X, et al. Eur J Med Chem. 2009 Oct;44(10):4090-7. doi: 10.1016/j.ejmech.2009.04.050. Epub 2009 May 15. Eur J Med Chem. 2009. PMID: 19497644

3

Recent advances in the development of small-molecule CCR5 inhibitors for HIV.

Liu T, Weng Z, Dong X, Hu Y. Liu T, et al. Among authors: dong x. Mini Rev Med Chem. 2010 Nov;10(13):1277-92. doi: 10.2174/13895575110091277. Mini Rev Med Chem. 2010. PMID: 20854256 Review.

4

Integrating docking scores, interaction profiles and molecular descriptors to improve the accuracy of molecular docking: toward the discovery of novel Akt1 inhibitors.

Zhan W, Li D, Che J, Zhang L, Yang B, Hu Y, Liu T, Dong X. Zhan W, et al. Among authors: dong x. Eur J Med Chem. 2014 Mar 21;75:11-20. doi: 10.1016/j.ejmech.2014.01.019. Epub 2014 Jan 22. Eur J Med Chem. 2014. PMID: 24508830

5

Design, synthesis and biological evaluation of pyrazol-furan carboxamide analogues as novel Akt kinase inhibitors.

Zhan W, Xu L, Dong X, Dong J, Yi X, Ma X, Qiu N, Li J, Yang B, Zhou Y, Hu Y. Zhan W, et al. Among authors: dong x, dong j. Eur J Med Chem. 2016 Jul 19;117:47-58. doi: 10.1016/j.ejmech.2016.03.074. Epub 2016 Apr 5. Eur J Med Chem. 2016. PMID: 27089211

6

Design, synthesis, and molecular docking study of 3H-imidazole[4,5-c]pyridine derivatives as CDK2 inhibitors.

Wu YZ, Ying HZ, Xu L, Cheng G, Chen J, Hu YZ, Liu T, Dong XW. Wu YZ, et al. Arch Pharm (Weinheim). 2018 Jun;351(6):e1700381. doi: 10.1002/ardp.201700381. Epub 2018 Apr 30. Arch Pharm (Weinheim). 2018. PMID: 29708285

7

Cysteine-targeted Irreversible Inhibitors of Tyrosine Kinases and Key Interactions.

Hu C, Dong X. Hu C, et al. Among authors: dong x. Curr Med Chem. 2019;26(31):5811-5824. doi: 10.2174/0929867325666180713124223. Curr Med Chem. 2019. PMID: 30009703 Review.

8

Development of Macrocyclic Peptides Containing Epoxyketone with Oral Availability as Proteasome Inhibitors.

Li D, Zhang X, Ma X, Xu L, Yu J, Gao L, Hu X, Zhang J, Dong X, Li J, Liu T, Zhou Y, Hu Y. Li D, et al. Among authors: dong x. J Med Chem. 2018 Oct 25;61(20):9177-9204. doi: 10.1021/acs.jmedchem.8b00819. Epub 2018 Oct 12. J Med Chem. 2018. PMID: 30265557

9

Covalent docking modelling-based discovery of tripeptidyl epoxyketone proteasome inhibitors composed of aliphatic-heterocycles.

Dong XW, Zhang JK, Xu L, Che JX, Cheng G, Hu XB, Sheng L, Gao AH, Li J, Liu T, Hu YZ, Zhou YB. Dong XW, et al. Eur J Med Chem. 2019 Feb 15;164:602-614. doi: 10.1016/j.ejmech.2018.12.064. Epub 2018 Dec 26. Eur J Med Chem. 2019. PMID: 30639896

10

Identification of new NIK inhibitors by discriminatory analysis-based molecular docking and biological evaluation.

Cheng G, Mei XB, Yan YY, Chen J, Zhang B, Li J, Dong XW, Lin NM, Zhou YB. Cheng G, et al. Arch Pharm (Weinheim). 2019 Jul;352(7):e1800374. doi: 10.1002/ardp.201800374. Epub 2019 May 22. Arch Pharm (Weinheim). 2019. PMID: 31116887

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,000 results

Search Page

Filters